Pharmabiz1d
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies
Harbour BioMed launches Élancé Therapeutics to advance next-generation obesity therapies: Cambridge, Massachusetts Thursday, March 13, 2025, 18:00 Hrs [IST] Harbour BioMed, a gl ...
Pharmabiz1d
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes
Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...
Pharmabiz1d
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant
Wockhardt Hospitals, Mira Road successfully performs first Swap Kidney Transplant: Our Bureau, Mumbai Thursday, March 13, 2025, 17:40 Hrs [IST] In a significant development that c ...
Pharmabiz1d
Mankind Pharma launches affordable empagliflozin in India for diabetes
Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...
Pharmabiz1d
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections
PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections: Petach Tikva, Israel Thursday, March 13, 2025 ...
Pharmabiz1d
Lipocine announces US FDA labelling changes for testosterone products
Lipocine announces US FDA labelling changes for testosterone products: Salt Lake City Thursday, March 13, 2025, 16:00 Hrs [IST] Lipocine Inc., a biopharmaceutical company leveragi ...
Pharmabiz1d
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
Pharmabiz1d
SunAct Cancer Institute partners with Smita Memorial Hospital and India’s oncology pioneer Dr Suresh Advani to redefine cancer treatment
Our Bureau, Mumbai Thursday, March 13, 2025, 14:15 Hrs [IST] ...
Pharmabiz1d
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems: Our Bureau, Bengaluru Thursday, March 13, 2025, 14:30 Hrs [ ...
Pharmabiz1d
SK bioscience begins shipping of its self-developed influenza vaccine, SKYCellflu to Southern Hemisphere market
SK bioscience begins shipping of its self-developed influenza vaccine, SKYCellflu to Southern Hemisphere market: Seongnam, South Korea Thursday, March 13, 2025, 14:00 Hrs [IST] SK ...
Pharmabiz1d
Encube R&D centre for the life sciences industry opens at Palava
Encube R&D centre for the life sciences industry opens at Palava: Our Bureau, Mumbai Thursday, March 13, 2025, 13:45 Hrs [IST] Encube Ethicals has officially opened its flagship r ...
Pharmabiz1d
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...